News

St. Anna CCRI attends “Better Medicines for Children Conference 2022” (Vienna, 20.10.2022) We are happy to attend the “EFGCP Better Medicines for Children Conference 2022” with Ruth Ladenstein (Principal Investigator at St. Anna CCRI) presenting the EU funded “European Rare Disease Research Coordination and Support Action – ERICA” in the panel discussion “Rare diseases – […]

This year, all three prizes, as well as the “best abstract of the conference” go to St. Anna Children’s Cancer Research Institute (St. Anna CCRI) and St. Anna Children’s Hospital!

Socializing, getting further education and screening job offers: This year’s Life Science Career Fair of the ÖGMBT offered a wide range of opportunities for students and graduates.

A great success! Dr. Eva König, principal investigator at St. Anna CCRI, is honored with the Heribert-Konzett-Prize of the Austrian Pharmacological Society (APHAR) for her scientific work on the interaction between immune and cancer cells. The prize is awarded to recognize the achievements of young scientists already conducting independent research in the field of experimental and clinical pharmacology and to encourage their further development.

September is Childhood Cancer Awareness Month – a month dedicated to remind us of the dire need to find more and better cures for this devastating disease.

St. Anna Childhood Cancer Researcher Michael Dworzak explains which question drives him, what matters in research/life and how to keep cool on hot summer days.

St. Anna Children’s Cancer Researcher Sabine Taschner-Mandl strives to improve the treatment of childhood nerve tumors. We asked what arouses her curiosity and how she spends her summer holidays.

This year’s 1000 ideas program of FWF promotes another two of St. Anna CCRI’s “completely new, daring or particularly original research ideas that lie outside the current scientific understanding”. Florian Halbritter’s new approach aims to integrate machine learning directly into the experimental design and execution of manufacturing specific cell types from stem cells – with the ultimate goal to reprogram even cancer cells. Artem Kalinichenko, who was also awarded a 1000 ideas grant, is targeting abnormal tumor metabolism by identifying cancer-derived metabolites, drugs and drug metabolites that trigger an immune reaction, which could later be exploited for immunotherapy.

Scientists off the record: St. Anna Children’s Cancer Researcher René Geyeregger reveals how he spends his summer vacation, what he is curious about and what drives him in research.

To find vulnerabilities of cancers that are driven by MYC, a protein known for its potential to induce tumor growth, is the goal of a new project funded by the Austrian Science Fund FWF. Davide Seruggia from St. Anna Children’s Cancer Research Institute (St. Anna CCRI) and colleagues aim to deactivate this key cancer regulator by targeting components of SAGA, a protein complex tightly linked to MYC. Since pediatric leukemia and neuroblastoma, two of the most common childhood cancers are known to be driven by MYC, establishing new strategies to interrupt its activity in cancer cells is of utmost importance.